Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to 0.05%.

  • Kiniksa Pharmaceuticals International's Return on Invested Capital rose 1100.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.12% for FY2024, which is 800.0% down from last year.
  • Kiniksa Pharmaceuticals International's Return on Invested Capital amounted to 0.05% in Q3 2025, which was up 1100.0% from 0.0% recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Return on Invested Capital registered a high of 0.41% during Q3 2022, and its lowest value of 0.79% during Q4 2021.
  • For the 5-year period, Kiniksa Pharmaceuticals International's Return on Invested Capital averaged around 0.11%, with its median value being 0.05% (2024).
  • Examining YoY changes over the last 5 years, Kiniksa Pharmaceuticals International's Return on Invested Capital showed a top increase of 9400bps in 2023 and a maximum decrease of -4600bps in 2023.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Return on Invested Capital stood at 0.79% in 2021, then skyrocketed by 109bps to 0.07% in 2022, then plummeted by -156bps to 0.04% in 2023, then crashed by -215bps to 0.12% in 2024, then surged by 144bps to 0.05% in 2025.
  • Its Return on Invested Capital was 0.05% in Q3 2025, compared to 0.0% in Q2 2025 and 0.09% in Q1 2025.